Bicara Therapeutics BCAX Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Bicara Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's book value per share?
- Bicara Therapeutics (BCAX) reported book value per share of $8.46 in Q1 2026.
- How has Bicara Therapeutics's book value per share changed year-over-year?
- Bicara Therapeutics's book value per share increased by 0.4% year-over-year, from $8.43 to $8.46.
- What is the long-term trend for Bicara Therapeutics's book value per share?
- Over 2 years (2023 to 2025), Bicara Therapeutics's book value per share has grown at a -83.1% compound annual growth rate (CAGR), from -$256.45 to $7.34.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.